Clinical Trials Logo
  1. Home
  2. Pelvic Pain Syndrome
  3. NCT05344716

FotonaSmooth Erbium:YAG Laser for the Treatment of Urethral Pain Syndrome in Women — UPS-IUL  

Pelvic Pain Syndrome Clinical Trial

Official title:
Monocentric, Prospective Pilot Study to Test the Efficacy and Safety of the FotonaSmooth Erbium:YAG Laser for the Treatment of Urethral Pain Syndrome in Women

Clinical Trial Summary

Urethral pain syndrome (UPS) is defined by the occurrence of persistent or recurrent episodic urethral pain in the absence of proven infection or other obvious pathology. The objective of this study is to determine the effect of an intraurethral and vaginal laser therapy for the treatment of UPS. The hypothesis is that a significant reduction of urethral pressure pain can be achieved.

Clinical Trial Description

Urethral pain syndrome (UPS) is characterized by recurrent or persistent symptoms such as urethral or pelvic pain, daytime frequency and nocturia with unclear aetiology are diagnosed as UPS. Chronic infection by fastidious bacteria leading to chronic inflammation and pain may also cause UPS. Due to the unclear aetiology, the optimal treatment is challenging. It is therefore essential to find new and effective treatment options for patients suffering from UPS. Over the last few years, the use of lasers has become more popular to treat gynaecological and urogynecological conditions including stress urinary incontinence (SUI), genitourinary syndrome of menopause (GSM), vaginal prolapse and other conditions. In several trials, vaginal laser therapy has been shown to have a very good effect on SUI and GSM. Very few publications are available on the use of intraurethral laser therapy for the treatment of SUI and GSM with promising results. This is the first study to test the effect of intraurethral and vaginal laser therapy for the treatment of UPS. The hypothesis is that symptoms can be relieved in patients with UPS i.e. a reduction of urethral pressure pain upon palpation can be achieved. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05344716
Study type Interventional
Source Cantonal Hospital, Frauenfeld
Contact Volker Viereck, Prof. Dr.
Phone +41 52 723 70 60
Email volker.viereck@stgag.ch
Status Recruiting
Phase N/A
Start date September 1, 2022
Completion date December 2026
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03252041 - MRI & MRV in Pelvic Congestion Syndrome in Females N/A
Completed NCT03671993 - Clinical Effect Observation for Electrical Pudendal Nerve Stimulation in Treating Urethral Pain Syndrome N/A
Completed NCT03715777 - Electromyographic Study for the Help and Guidance of BoNTA Administration in the Treatment of Chronic Pelvic Floor Pain Phase 3
Withdrawn NCT04046406 - Pelvic Pain Treated With MR-guided Cryoanalgesia N/A
Recruiting NCT06124664 - Study of Venous Outflow From the Lower Limbs in Patients With Pelvic Varicosities
Not yet recruiting NCT03943381 - Duplex US in Pelvic Congestion Syndrome in Females (PCS)
Completed NCT03797911 - Efficacy of Resistive Capacitive Monopolar Radiofrequency in the Physiotherapeutic Treatment of Chronic Pelvic Pain: RCT N/A
Not yet recruiting NCT06168058 - Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices N/A
Recruiting NCT05489133 - Early Psychological Intervention After Rape N/A
Not yet recruiting NCT04910672 - Primary Dysmenorrhea and Osteopathic Treatment N/A
Completed NCT04135118 - Validation of the Adenomyosis Calculator
Recruiting NCT06102733 - Chronic Pelvic Pain in Females and Males
Recruiting NCT06369545 - Chronic Pelvic Pain Syndrome in Males N/A
Enrolling by invitation NCT05513417 - Digital Care Programs for Female Pelvic Health
Completed NCT06080828 - Transdermal Neuromodulation for Management of Chronic Pelvic Pain in Women N/A